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1. Introduction 
Fatty acids possess many crucial functions in the organism. 
Apart from being constituents of cell membranes, energy source, 
inflammatory responses and exclusive building blocks for the 
synthesis of lipids and fats, they are employed in many 
interesting scientific applications. For example, they are used as 
dietary supplements to treat depressive symptoms,1 as signaling 
probes in cancer development,2 as cardiac biomarkers for early 
diagnosis of myocardial infarction,3 as metabolic controllers of 
cardiac function,4 in the treatment of neuropsychiatric disorders,5 
in pathogenesis and treatment of Alzheimer's disease and type 2 
diabetic dementia,6 in hormonal control,7 etc.  
The synthetic transformations of fatty acid derivatives into 
valuable chemicals is desirable since the industrial point of 
view.8 In addition, it has been demonstrated that an alteration in 
the polar part of these molecules produced changes in their 
activity as modulators of membrane structure, microdomain 
organization and cellular signaling.9 With this idea, the 
employment of the fatty acids as starting materials wa  envisaged 
to prepare their corresponding α-amino esters and, in the final 
step, run the 1,3-dipolar cycloaddition (1,3-DC) between them 
and several representative dipolarophiles (Scheme 1). The main 
goal is to construct a polar unit (prolinate or proline) together 
with a long chain attached at the 2-position of the heterocycle. 
 
Scheme 1. Retrosynthetic pathway to obtain long chain-
substituted proline derivatives. 
 
2. Results and Discussion 
First of all, the synthesis of amines 5, derived from fatty acids 
1 was carried out due to they are not commercially avail ble. 
They were synthesized following the procedure described in the 
literature.10 The procedure consisted in an α-hydroxylation of the 
commercial fatty acids: oleic acid (OA), linolenic acid (LA), 
docosahexaenoic acid (DHA) and arachidonic acid (ARA). Next, 
the synthesis of the corresponding α-phthalimides 4 via 
Mitsunobu reaction of 3 and finally, the conventional Gabriel’s 
synthesis using, in this last step, the Ing–Manske work-up 
(Scheme 2) was sequentially performed in this order. With this 
methodology the desired products 5 were achieved in good 
overall chemical yields from starting materials 3. 
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Scheme 2. Synthesis of long chain α-amino esters 5. 
 
These α-amino esters 5 were allowed to participate in a 
multicomponent 1,3-dipolar cycloaddition (1,3-DC) with 
electrophilic alkenes and aldehydes. According to precedent 
surveys in our group,11 toluene was selected as solvent and silver 
acetate as catalyst. After several optimization tests of the 
cycloaddition involving 5a, benzaldehyde and N-methyl 
maleimide (NMM) took place at room temperature and no added 
base was necessary. The reaction was completed after 16 hours 
being crucial the presence of silver acetate (5 mol%). The 
absence of the silver salt supposed low conversions and very 
complex reaction mixtures in the crude material (analyzed by 1H 
NMR spectroscopy). The final endo-cycloadduct 6aa was 
isolated as pure compound in 78% yield (Scheme 3). This same 
procedure was extended to other maleimides and acrylic systems 
furnishing high yields of the corresponding cycloadducts 6a. 
However, when acrylates were employed as dipolarophiles, th  
best results were obtained following the sequential order of 
addition: the amine (1 equiv.) and aldehyde (1 equiv.) were 
mixed in toluene during 2 h at 70 °C, then acrylate (1 quiv.) and 
the catalyst were added and stirred 16 h at this temperature.  
When the same sequential methodology was attempted, a  room 
temperature, the conversion was very poor. endo-Cycloadduct 
6ah was prepared by the multicomponent route at 70 °C whilst 
endo-6ag was generated using ethanol11 instead of toluene. The 
presence of chromenone, a 3-indolyl substituent and 2-thiazolyl 
residues in the molecule, as occurred in products 6ag-6ai can 






Scheme 3. 1,3-DC to obtain prolinates derived from α-amino 
ester 5a. 
 
α-Amino ethyl ester 5b derived from linoleic acid 1b behaved 
similarly to α-amino ester 5a. The cleanest reaction occurred in 
toluene at room temperature in presence of 5 mol% of silver 
acetate as catalyst. The reaction between benzaldehyde, 5b and 
different dipolarophiles (6ba-6bc) was successfully performed. 
All of them were obtained in moderate to good yields and high 
endo-diastereoselectivity after flash column chromatography. It 
was also tested with different aldehydes bearing a 

















Scheme 4. 1,3-DC to obtain prolinates derived from α-amino 
ester 5b 
 
α-Amino esters 5c and 5d, obtained from ARA and DHA 
respectively, also were suitable precursors for this 
multicomponent 1,3-DC remaining unaltered all the conjugated 
insaturations. The high endo-diastereoselectivity was also kept 
and the chemical yields of compounds 6c and 6d were relatively 




Scheme 5. Synthesis of prolinates endo-6c and endo-6d derived 
from α-amino ester 5c and α-amino ester 5d, respectively. 
 
It is well known that a small change in the amino acid 
unit/protein is associated in biological engineering to evolution. 
Apparently, both of mutated entities are capable of exhibiting 
analogous biological properties acting as invariant residues, but 
in other scenarios a considerable variation of bioact vity can 
occur calling that variable residues.12 Considering compounds 6 
as synthetic surrogates of racemic prolinates, and expand the 
interest and utility of this methodology in general science, we 
focused on this study  towards the preparation of the homologue 
α-amino acid 11a (with respect to compound 5a, derived from 
OA).13 Thus, the preparation of racemic N-tert-butylsulfinyl 
imine 8a was accomplished in very good yield from the 
corresponding alcohol 7a (Scheme 6). Next, the addition of 
nitromethane-Neff reaction were successfully carried out in high 
conversions giving compound 10a in moderate yields (41%).14 
Final one-pot esterification and removal of the sulfiny  group 
afforded the amino ester 11a in 82% yield (Scheme 6). 
 
 
Scheme 6. Synthesis of the homologue α-amino ester 11a. 
 
The multicomponent 1,3-dipolar reaction between 11a, 
benzaldehyde and NMM was carried out following identical 
reaction conditions described in Schemes 3-5. Product endo-
cycloadduct 12aa was diastereoselectively formed and isolated in 
75% yield (Scheme 7). So, this cycloadduct is integrated by from 
a non-natural side chain, which is homologous to the 
corresponding molecules endo-6aa.  
 
Scheme 7. Synthesis of prolinate 12aa derived from homologous 
α-amino ester 11a.   
 
In every reaction the ndo-cycloadducts were obtained almost 
exclusively not only after chromatographic separation but in the 
raw material (observed by 1H NMR spectroscopy). This relative 
configuration was supported by analysis of nOe experiments and 
by comparison of the coupling constant values with similar 
substances isolates in previous contributions.11  At this moment 
the biological evaluation of them against tumor cells, bacteria 



















The preparation of new amino acid and prolinate derivatives, 
incorporating a long side chain at the α-position of the carbonyl 
group, was reported. These amino esters were also sati factorily 
prepared in good yields and many of them are new compounds. 
The multicomponent cycloaddition operated under mild 
conditions, total atom economy and excellent 
diastereoselectivity. The stereochemical outcome of the novel 
prolinate derivatives provided an all-cis-arrangement [positions 
2, 3 (for maleimides), 4 and 5). The biological interest of these 
amino esters and cycloadducts obtained through the 
multicomponent 1,3-DC are unpredictable. The efficient one 
atom elongation in the long side hydrophobic chain gave access 
to both homologous: a) new amino ester, and b) prolinate 
surrogate, which can be potentially interesting in many scientific 
areas. 
 
4. Experimental section 
4.1 General information. 
All commercially available reagents and solvents were used 
without further purification, only aldehydes were also distilled 
prior to use. Analytical TLC was performed on Schleich r & 
Schuell F1400/LS 254 silica gel plates, and the spots were 
visualized under UV light (λ 254 nm). Flash chromatography 
was carried out on hand-packed columns of Merck silica gel 
60 (0.040-0.063 mm). The structurally most important peaks 
of the IR spectra (recorded using a Nicolet 510 PFT) are listed 
and wave numbers are given in cm-1. NMR spectra were 
obtained using a Bruker AC-300 or AC-400 and were 
recorded at 300 or 400 MHz for 1H NMR and 75 or 100 MHz 
for 13C NMR, using CDCl3 as solvent and TMS as internal 
standard (0.00 ppm). The following abbreviations are used to 
describe peak patterns where appropriate: s ¼ singlet, d ¼ 
doublet, t ¼ triplet, q ¼ quartet, m¼ multiplet or unresolved 
and br s ¼ broad signal. All coupling constants (J) are given 
in Hz and chemical shifts in ppm. 13C NMR spectra were 
referenced to CDCl3 at 77.16 ppm. DEPT-135 experiments 
were performed to assign CH, CH2 and CH3. 
19F NMR were 
recorded at 282 MHz using CDCl3 as solvent. Low resolution 
electron impact (EI) mass spectra were obtained at 70 eV 
using a Shimadzu QP-5000 by injection or DIP; fragment ions 
in m/z are given with relative intensities (%) in parentheses. 
High resolution mass spectra (HRMS) were measured on an 
instrument using a quadrupole time-of-flight mass 
spectrometer (QTOF) and also through the electron impact 
mode (EI) at 70 eV using a Finnigan VG Platform or a 
Finnigan MAT 95 S.  
 
4.2. General procedure for the preparation of α-hydroxy fatty 
esters 3a. 
To a solution of the fatty ester 2a (2.82 g, 10 mmol) in 
anhydrous THF (10 mL) was added lithium diisopropylamine 
2.5 M (8 mL, 20 mmol) in tetrahydrofuran (15 mL) at -0 °C to 
provide the ester enolate. This ester enolate was bubbled with 
molecular oxygen (25 mmol) during 1 h. The mixture was 
hydrolyzed with 3M HCl and it was extracted with diethyl 
ether. The organic phase was dried (MgSO4), filtered, 
evaporated under vacuum and purified by flash column 
chromatography on silica gel eluting with mixtures of n-
hexane/AcOEt.  
 
Ethyl (Z)-2-hydroxyoctadec-9-enoate 3a. 
Colorless oil, (2.45g, 75% yield). Rf 0.47 (hexane/ethyl 
acetate: 8/2). IR (neat) ʋmax: 1106, 1213, 1464, 1731, 2854, 
2925, 3500 cm-1. 1H NMR (300 MHz, CDCl3) δ) δ 5.36-5.33 
(m, 2H), 4.25 (q, J = 7.2 Hz, 2H), 4.16 (dd, J = 7.2, 4.1 Hz, 
1H), 2.73 (s, 1H), 2.05-1.99 (m, 4H), 1.83-1.74 (m,1H), 1.68-
1.59 (m, 1H), 1.48-1.21 (m, 23H), 0.90-0.87 (m, 3H). 13C 
NMR (75 MHz, CDCl3) δ: 175.4, 130.0, 129.7, 70.4, 61.5, 
34.4, 31.9, 29.8, 29.6, 29.5, 29.3, 29.2, 29.1, 27.2, 27.1, 24.7, 
22.7, 14.2, 14.1. LRMS (EI): m/z = 326 (M+, <1%) 253 (100), 
123 (23), 121 (27), 111 (27), 109 (41), 104 (53), 97 (49), 95 
(73), 81 (70), 55 (80). HRMS (EI): calcd. for C20H38O3 
326.2821; found 326.2826. 
 
4.3. General procedure for the preparation of α-hydroxy fatty 
esters 3b-d. 
Fatty ester 2b-d (10 mmol) was dissolved in anhydrous THF 
(10 mL) and treated with potassium bis(trimethylsil)amide 
0.45 M (44 mL, 20 mmol) in tetrahydrofuran (15 mL), at -78 
°C for 1 h. This ester enolate reacted with (phenylsulfonyl)-3-
phenyloxaziridine (6.53 g, 25 mmol) giving α-hydroxy fatty 
esters 3b-d. After 19 h at room temperature, the mixture was 
hydrolyzed with 3M HCl and it was extracted with diethyl 
ether. The organic phase was dried (MgSO4), filtered, 
evaporated under vacuum and purified by flash column 
chromatography on silica gel eluting with n-hexane/AcOEt. 
 
Ethyl (9Z,12Z)-2-hydroxyoctadeca-9,12-dienoate 3b. 
Yellow oil, (2.17g, 67% yield). Rf 0.52 (hexane/ethyl acetate: 
8/2). IR (neat) ʋmax: 1110, 1209, 1466, 1735, 2856, 2927, 
3449 cm-1. 1H NMR (300 MHz, CDCl3) δ 5.44-5.33 (m, 4H), 
4.23 (qd, J = 7.2, 1.4 Hz, 2H),  4.15 (ddd, J = 7.2, 5.7, 4.2 Hz, 
1H), 2.91 (dd, J = 5.7, 2.6 Hz, 1H), 2.76 (t, J = 6.4 Hz, 2H), 
2.04 (q, J = 6.4 Hz, 4H), 1.80-1.73 (m, 1H), 1.64-1.58 (m, 
1H), 1.47-1.17 (m, 17H), 0.88 (t, J = 6.8 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ: 175.4, 130.1, 129.9, 128.0, 127.9, 70.4, 
61.5, 34.4, 31.5, 29.5, 29.3, 29.2, 29.1, 27.2, 27.1, 25.6, 24.7, 
22.5, 14.1, 14.0. LRMS (EI): m/z = 324 (M+, <1%) 251 (18), 
110 (25), 109 (39), 96 (41), 95 (79), 93 (29), 81 (96), 69 (42), 
67 (100), 55 (68), 41 (46). HRMS (EI): calcd. for C20H36O3 




Yellow oil, (2.10g, 63% yield). Rf 0.50 (hexane/ethyl acetate: 
8/2). IR (neat) ʋmax: 1113, 1216, 1440, 1738, 2857, 2927, 
2955, 3012, 3452 cm-1. 1H NMR (300 MHz, CDCl3) δ 5.50-
5.31 (m, 8H), 4.20 (dt, J = 8.3, 4.2 Hz, 1H), 3.79 (s, 3H), 
2.86-2.81 (m, 6H), 2.30-2.18 (m, 2H), 2.09-2.04 (m, 2H), 
1.91-1.83 (m, 1H), 1.76-1.67 (m, 1H), 1.39-1.26 (m,6H), 0.90 
(t, J = 6.8 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.7, 
130.5, 129.2, 128.6, 128.5, 128.2, 128.1, 127.9, 127.5, 69.8, 
52.5, 34.1, 31.5, 29.3, 27.2, 25.6, 25.6, 22.6, 22.5, 14.0. 
LRMS (EI): m/z = 334 (M+, <1%) 129 (25), 109 (28), 101 














(47), 69 (56), 57 (57), 55 (88), 43 (100), 41 (67). HRMS (EI): 




Yellow oil, (2.53g, 68% yield). Rf 0.48 (hexane/ethyl acetate: 
8/2). IR (neat) ʋmax: 1110, 1206, 1445, 1735, 2964, 3013, 
3412 cm-1. 1H NMR (300 MHz, CDCl3) δ 5.60-5.32 (m, 12H), 
4.27-4.20 (m, 3H), 2.89-2.79 (m, 10H), 2.59-2.47 (m, 2H), 
2.12-2.02 (m, 2H), 1.29 (t, J = 7.1 Hz, 1H), 0.97 (t, J = 7.5 
Hz, 1H). 13C NMR (75 MHz, CDCl3) δ: 174.6, 132.0, 131.6, 
128.6, 128.4, 128.3, 128.1, 127.9, 127.8, 127.0, 123.4, 70.1, 
61.7, 32.2, 25.8, 25.6, 25.5, 20.6, 14.3, 14.2. LRMS (EI): m/z 
= 372 (M+, <1%), 145 (19), 131 (27), 119 (49), 117 (33), 108 
(35), 105 (49), 93 (50), 91 (85), 79 (100), 67 (59), 55 (26). 
HRMS (EI): calcd. for C24H36O3 372.2664; found 372.2664. 
 
4.4. General procedure for the preparation of α-amino fatty 
esters 5. 
A mixture of the α-hydroxylated ester 3 (7.00 mmol), 
phthalimide (1.24 g, 8.4 mmol) and triphenylphosphine (2.20 
g, 8.4 mmol) in 50 mL of THF was cooled to 0 °C under N2-
atmosphere before diisopropyl azodicarboxylate (1.72 mL, 
8.75 mmol) was added dropwise. The ice-bath was remov d 
and the reaction mixture was stirred at room temperature for 
18 h. Then, it was evaporated under vacuum and α-
phthalimide alkyl ester 4 was isolated after flash column 
chromatography on silica gel. Then, a solution of compound 4 
(5 mmol) in 15 mL of EtOH (for 4c, MeOH), was added 
hydrazine (0.40 mL, 7.5 mmol) and the resulting mixture was 
refluxed under N2-atmosphere for 48 h followed by 
evaporation under vacuum and purification by flash column 
chromatography on silica gel eluting with n-hexane/AcOEt .
 
Ethyl (Z)-2-aminooctadec-9-enoate 5a.  
Yellow oil, (1.64 g, 72% yield). Rf 0.26 
(dichloromethane/methanol: 3/1). IR (neat) ʋmax: 1180, 1465, 
1736, 2853, 2922, 3196, 3311, 3371 cm-1. 1H NMR (300 
MHz, CDCl3) δ 5.32-5.28 (m, 2H), 4.16 (q, J = 7.1 Hz, 2H), 
3.41 (td, J = 6.4, 5.3, 1.7 Hz, 1H), 2.00-1.94 (m, 5H), 1.78-
1.59 (m, 1H), 1.63-1.46 (m, 1H), 1.45-1.06 (m, 23H), 0.84 (t, 
J = 6.4 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 176.2, 130.1, 
129.8, 60.8, 54.5, 35.0, 32.0, 29.8, 29.7, 29.6, 29.4, 29.2, 27.3, 
27.2, 25.7, 22.8, 14.3, 14.1. LRMS (EI): m/z = 325 (M+, 
<1%), 254 (19), 253 (18), 252 (100), 56 (12). HRMS (EI): 
calcd. for C20H39NO2 325.2981; found 325.2983. 
 
Ethyl (9Z,12Z)-2-aminooctadeca-9,12-dienoate 5b. 
Yellow oil, (1.49 g, 66% yield). Rf 0.25 
(dichloromethane/methanol: 9/3). IR (neat) ʋmax: 1181, 1465, 
1736, 2854, 2925, 3301, 3375 cm-1. 1H NMR (300 MHz, 
CDCl3) δ 5.38-5.25 (m, 4H), 4.16 (qd, J = 7.2, 1.7 Hz, 2H), 
3.40 (dd, J = 7.4, 5.4 Hz, 1H), 2.73 (t, J = 6.3 Hz, 2H), 2.04-
1.99 (m, 5H), 1.73-1.67 (m, 1H), 1.58-1.51 (m, 1H), 1.48-1.14 
(m, 17H), 0.87-0.84 (m, 3H). 13C NMR (75 MHz, CDCl3) δ: 
175.8, 129.9, 129.7, 127.8, 127.6, 60.5, 54.2, 34.6, 31.3, 29.3, 
29.1, 28.9, 26.9 (2), 25.4, 25.3, 22.3, 14.0, 13.8. LRMS (EI): 
m/z = 323 (M+, <1%), 252 (53), 250 (100), 67 (12), 56 (19). 





Yellow oil, (1.60 g, 64% yield). Rf 0.29 
(dichloromethane/methanol: 97/3). IR (neat) ʋmax: 1185, 1392, 
1445, 1735, 2964, 3012, 3309, 3377 cm-1. 1H NMR (300 
MHz, CDCl3) δ 5.43-5.32 (m, 12H), 4.18 (q, J = 7.1 Hz, 2H), 
3.52 (dd, J = 7.1, 5.2 Hz, 1H), 2.89-2.80 (m, 10H), 2.59-2.37 
(m, 2H), 2.12-1.95 (m, 3H), 1.28 (t, J = 7.1 Hz, 3H), 0.97 (t, J
= 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.4, 132.1, 
131.6, 128.6, 128.5, 128.3, 128.0, 127.9, 127.8, 127.1, 124.6, 
61.0, 54.3, 32.6, 25.7, 25.6, 20.6, 14.4, 14.3. LRMS (EI): m/z 
= 371 (M+, <1%), 298 (17), 102 (100), 91 (15), 74 (16). 
HRMS (EI): calcd. for C24H37NO2 371.2824; found 371.2829. 
 
4.5. General procedure for the preparation of prolinates 6 
and 12. 
Synthesis of 6 and 12 with maleimides as dipolarophile: 
Multicomponent reaction: to a stirred solution of α-amino 
ester 5 or 11a (0.5 mmol) in toluene (3 mL) or EtOH (for 
6ag), aldehyde (0.5 mmol) was added. After that, the 
maleimide (0.5 mmol) and AgOAc (4.2 mg, 5 mol%) were 
added in this order. The reaction mixture was stirred 
overnight at room temperature (at 70 °C for6ag and 6ah). 
Then, it was extracted with ethyl acetate and washed with 
brine. The organic phase was dried (MgSO4), filtrated and 
evaporated. The corresponding pyrrolidines were obtained in 
good yields after purification by flash chromatography 
(Hexane/AcOEt). 
 
Synthesis of 6 with acrylates as dipolarophile: Sequential 
reaction: to a stirred solution of α-amino ester 5 (1 equiv., 0.5 
mmol) in toluene (3 mL), aldehyde (1 equiv., 0.5 mmol) was 
added and the mixture was stirred during 2 h at 70 °C. Then 
acrylate (1 equiv., 0.5 mmol) and the catalyst AgOAc (4.2 
mg, 5 mol%) were added and stirred 16 h at this temperature. 
The crude mixture was extracted with ethyl acetate nd 
washed with brine. The organic phase was dried (MgSO4), 
filtrated and evaporated. The corresponding pyrrolidines were 






Yellow oil, (205 mg, 78% yield). Rf 0.30 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1287, 1383, 1435, 1705, 1779, 
2854, 2925, 3343, 3466 cm-1. 1H NMR (300 MHz, CDCl3) δ: 
7.38-7.31 (m, 5H), 5.45-5.20 (m, 2H), 4.66 (d, J = 9.1 Hz, 
1H), 4.47-4.21 (m, 2H), 3.52 (dd, J = 9.1, 7.4 Hz, 1H), 3.27 
(d, J = 7.4 Hz, 1H), 2.81 (s, 3H), 2.13-2.01 (m, 4H), 1.84-1.75 
(m, 1H), 1.43-1.27 (m, 25H), 0.92-0.87 (m, 3H). 13C NMR 
(75 MHz, CDCl3) δ: 175.7, 174.8, 171.6, 137.1, 130.1, 129.6, 
128.5, 128.4, 127.0, 70.7, 61.7, 55.4, 50.4, 35.0, 31.9, 29.7, 
29.7, 29.5, 29.4, 29.3, 29.0, 27.2, 27.1, 24.8, 23.6, 22.7, 14.1. 
LRMS (EI): m/z = 524 (M+, <1%), 454 (24), 453 (80), 452 
(32), 451 (100), 301 (88), 205 (15), 144 (19). HRMS (EI): 





Yellow oil, (235 mg, 76% yield). Rf 0.52 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1224, 1432, 1511, 1707, 2854, 
2925, 3348, 3464 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.30-


















5.45-5.29 (m, 2H), 4.63 (d, J = 9.0 Hz, 1H), 4.43 (dd, J = 7.4, 
3.7 Hz, 2H), 4.37 (dd, J = 11.2, 7.1 Hz, 2H), 3.46 (dd, J = 9.1, 
7.5 Hz, 1H), 3.25 (d, J = 7.5 Hz, 1H), 2.10-2.01 (m, 4H), 
1.88-1.68 (m, 1H), 1.43-1.03 (m, 25H), 0.92-0.88 (m, 3H). 
13C NMR (75 MHz, CDCl3) δ: 175.3, 174.3, 162.5 (d, 
1JC-F = 
246.7 Hz, CF), 131.6 (d, 4JC-F = 3.1 Hz, CCHCHCF), 131.1 
(d, 3JC-F = 8.2 Hz, CHCHCF), 130.2, 129.7, 128.5, 128.3, 
127.1, 115.4 (d, 2JC-F = 21.6 Hz, CHCF), 71.0, 61.9, 61.8, 
55.6, 50.2, 41.8, 35.1, 32.0, 29.9 , 29.8, 29.7, 29.6, 29.5, 29.4, 
29.2, 27.3, 27.2, 23.7, 22.8, 14.3, 14.2. 19F NMR δ: -114.2. 
LRMS (EI): m/z = 618 (M+, <1%), 545 (100), 395 (64), 144 
(13), 109 (47), 91 (8). HRMS (EI): calcd. for C38H51FN2O4  




Colorless oil, (195 mg, 78% yield). Rf 0.30 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax : 1201, 1248, 1456, 1731, 2854, 
2923, 3370, 3452 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.57-
7.30 (m, 5H), 5.43-5.32 (m, 2H), 4.85 (d, J = 6.4 Hz, 1H), 
4.32 (q, J = 7.1 Hz, 2H), 3.30-3.29 (m, 1H), 3.23 (s, 3H), 2.79 
(dd, J = 13.9, 3.6 Hz, 1H), 2.17 (dd, J = 13.7, 7.6 Hz, 1H), 
2.20-1.88 (m, 5H), 1.60-1.55 (m, 1H), 1.38-1.18 (m, 25H) 
0.89-0.85 (m, 3H). 13C NMR (75 MHz, CDCl3) δ: 172.8, 
169.1, 130.0, 129.7, 128.6, 128.2, 126.7, 65.6, 62.0, 51.4, 
49.7, 39.6, 31.9, 29.8, 29.7, 29.5, 29.3, 29.1, 27.2, 27.2, 25.0, 
22.7, 14.2, 14.1. LRMS (EI): m/z = 499 (M+, <1%), 428 (27), 
427(31), 426 (100), 276 (16), 105 (9). HRMS (EI): calcd. for 





Yellow oil, (237 mg, 86% yield). Rf 0.48 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1252, 1362, 1457, 1686, 1736, 
2853, 2924, 3312, 3359, 3452 cm-1. 1H NMR (300 MHz, 
CDCl3) δ:
 7.28-7.26 (m, 5H), 5.36-5.32 (m, 2H), 4.83 (s, 1H), 
4.35 (q, J = 7.1 Hz, 2H), 3.54-3.46 (m, 1H), 3.08-3.00 (m, 
1H), 2.84 (d, J = 12.8 Hz, 1H), 2.34-2.19 (m, 2H), 2.17-2.07 
(m, 2H) 2.09-1.94 (m, 5H), 1.93-1.90 (m, 2H), 1.79-1.67 (m, 
1H), 1.61-1.47 (m, 1H), 1.50-1.09 (m, 23H), 0.91-0.86 (m, 
3H). 13C NMR (75 MHz, CDCl3) δ: 175.5, 175.0, 173.8, 
130.1, 129.9, 128.1, 127.4, 66.2, 61.7, 45.6, 40.0, 33.6, 32.0, 
29.9, 29.8, 29.6, 29.4, 29.3, 27.3, 25.3, 22.8, 16.8, 14.5, 14.2. 
LRMS (EI): m/z = 552 (M+, <1%), 481 (30), 480 (38), 
479(100), 392 (12), 329 (21), 230 (11). HRMS (EI): calcd. for 





White solid, (250 mg, 90% yield). Rf 0.33 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1222, 1386, 1698, 1736, 1774, 
2853, 2924, 3361 cm-1. 1H NMR (300 MHz, CDCl3) δ:
 7.31-
7.28 (m, 5H), 5.36-5.31 (m, 2H), 4.78 (d, J = 6.0 Hz, 1H), 
4.32 (q, J = 7.0 Hz, 2H), 4.16-3.97 (m, 1H), 3.63 (q, J = 8.5, 
8.0 Hz, 2H), 3.29-3.06 (m, 1H), 2.80 (dd, J = 13.6, 3.6 Hz, 
1H), 2.10 (dd, J = 13.6, 7.1 Hz, 1H), 2.09-1.91 (m, 4H), 1.88 
(dd, J = 12.6, 4.5 Hz, 1H), 1.84-1.65 (m, 1H), 1.61-1.42 (m,
1H), 1.37-1.35 (m, 23H), 1.09-0.74 (m, 3H). 13C NMR (75 
MHz, CDCl3) δ: 175.5, 172.9, 152.8, 129.9, 129.7, 128.2, 
128.0, 127.0, 70.2, 65.8, 61.7, 48.4, 42.4, 39.6, 31.9, 29.7, 
29.7, 29.5, 29.3, 29.1, 27.2, 25.2, 22.7, 14.3, 14.1. LRMS 
(EI): m/z = 554 (M+, <1%), 483 (29), 482 (33), 481(100), 391 
(11), 331 (30), 156 (10). HRMS (EI): calcd. for C33H50N2O5  





Colorless oil, (172 mg, 58% yield). Rf 0.48 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1128, 1325, 1435, 1620, 1704, 
1780, 2855, 2925, 3342, 3467 cm-1. 1H NMR (300 MHz, 
CDCl3) δ 7.59 (d, J = 8.1 Hz, 2H), 7.47 (d, J = 8.1 Hz, 2H), 
5.41-5.28 (m, 2H), 4.66 (d, J = 8.9 Hz, 1H), 4.49-4.23 (m, 
2H), 3.53 (dd, J = 8.9, 7.4 Hz, 1H), 3.26 (d, J = 7.4 Hz, 1H), 
2.80 (s, 3H), 2.09-1.98 (m, 5H), 1.89-1.65 (m, 1H), 1.51-1.20 
(m, 25H), 0.90-0.78 (m, 3H). 13C NMR (75 MHz, CDCl3) δ:
 
175.4, 174.5, 171.4, 141.5, 130.3 (d, 2JC-F = 34.5 Hz, CHCF3), 
130.1, 129.5, 127.5, 125.8, 125.4, 125.3 (d, 3JC-F = 3.6 Hz, 
CHCHCF3), 125.2, 124.0 (d, 
1JC-F = 272.2 Hz, CF3), 70.6, 
61.67, 60.69, 55.0, 49.9, 34.9, 31.9, 29.7, 29.67, 29.6, 29.6, 
29.5, 29.3, 29.3, 29.0, 27.2, 27.1, 24.8, 23.6, 22.7, 14.1, 14.1. 
19F NMR δ: -62.5. LRMS (EI): m/z = 592 (M+, <1%), 521 
(42), 520 (44), 519 (100), 369 (68), 323 (17), 212 ( 8). 






Yellow oil, (254 mg, 84% yield). Rf 0.21 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1130, 1288, 1435, 1644, 1750, 
2854, 2924, 3056, 3315, 3460 cm-1. 1H NMR (300 MHz, 
CDCl3) δ:
 8.03 (s, 1H), 7.99 (d, J = 2.2 Hz, 1H), 7.49 (dd, J = 
8.6, 2.2 Hz, 1H), 7.35 (d, J = 8.6 Hz, 1H), 5.35-5.32 (m, 2H), 
4.66 (s, 1H), 4.35 (dqt, J = 17.8, 7.1, 3.6 Hz, 2H), 3.74 (t, J = 
8.2 Hz, 1H), 3.32 (d, J = 7.4 Hz, 1H), 2.85 (s, 3H), 2.45 (s, 
3H), 2.21-2.07 (m, 1H), 2.09-1.93 (m, 4H), 1.94-1.76 (m, 
1H), 1.38-1.13 (m, 24H), 0.87 (t, J = 6.8 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ: 177.9, 175.3, 174.9, 170.8, 154.6, 135.4, 
135.3, 130.0, 129.6, 125.1, 117.9, 71.6, 62.1, 55.4, 48.4, 35.0, 
31.9, 29.7, 29.7, 29.6, 29.5, 29.4, 29.3, 29.0, 27.2, 27.1, 25.1, 
23.9, 22.7, 20.9, 14.1. LRMS (EI): m/z = 606 (M+, <1%), 577 
(19), 533 (100), 383 (24), 337 (30), 297 (24). HRMS (EI): 





Red oil, (120 mg, 57% yield). Rf 0.43 (hexane/ethyl acetate: 
7/3). IR (neat) ʋmax: 1031, 1216, 1287, 1440, 1486, 1694, 
1776, 2854, 2925, 3360 cm-1. 1H NMR (300 MHz, CDCl3) δ:
  
8.72 (s, 1H), 7.18 (d, J = 8.8 Hz, 1H), 7.04 (d, J = 3.0 Hz, 
2H), 6.78 (dd, J = 8.8, 2.3 Hz, 1H), 5.38-5.28 (m, 2H), 4.97 
(d, J = 9.2 Hz, 1H), 4.50-4.28 (m, 2H), 3.81 (s, 3H), 3.56 (t, J 
= 8.4 Hz, 1H), 3.34 (d, J = 7.5 Hz, 1H), 2.69 (s, 3H), 2.11 (td, 














1.86 (t, J = 12.4 Hz, 1H), 1.40-1.20 (m, 25H), 0.89 (t, J = 6.7 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.9, 175.3, 171.7, 
153.9, 131.7, 130.1, 130.0, 129.6, 126.2, 123.8, 112.5, 112.3, 
100.7, 70.9, 61.9, 56.4, 55.9, 55.7, 50.0, 35.1, 31.9, 29.8, 29.7, 
29.6, 29.5, 29.5, 29.3, 29.1, 27.2, 27.2, 25.0, 23.8, 22.7, 14.1. 
LRMS (EI): m/z = 593 (M+, <1%), 520 (83), 482 (100), 371 
(35), 329 (45), 323 (22), 273 (96), 175 (26), 160 (36), 55 (27). 
HRMS (EI): calcd. for C35H51N3O5  593.3829; found 
593.3815. 




Yellow oil, (228 mg, 75% yield). Rf 0.15 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1397, 1705, 2854, 2925, 3312, 
3465 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.71 (dd, J = 5.6, 
3.2 Hz, 1H), 7.28-7.26 (m, 6H), 5.37-5.29 (m, 2H), 4.99 (d, J 
= 8.6 Hz, 1H), 4.47 (d, J = 2.0 Hz, 2H), 4.32 (qd, J = 7.2, 5.2 
Hz, 2H), 3.64 (t, J = 8.1 Hz, 1H), 3.29 (d, J = 7.3 Hz, 1H), 
2.01 (q, J = 6.7 Hz, 4H), 1.71-1.62 (m, 1H), 1.53-1.11 (m, 
25H), 0.91-0.86 (m, 3H).13C NMR (75 MHz, CDCl3) δ: 174.8, 
174.0, 170.6, 142.4, 135.3, 130.1, 129.6, 129.0, 128.5, 127.8, 
71.3, 61.8, 59.5, 55.7, 50.1, 42.7, 35.7, 31.9, 29.8, 29.6, 29.5, 
29.4, 29.3, 29.1, 27.3, 27.2, 23.8, 22.7, 14.2, 14.1. LRMS 
(EI): m/z = 607 (M+, <1%), 534 (100), 384 (39), 347 (22), 151 
(13), 91 (52), 86 (18). HRMS (EI): calcd. for C35H49N3O4S 





Yellow oil, (200 mg, 67% yield). Rf 0.57 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1168, 1346, 1431, 1707, 2855, 
2926, 3343, 3465 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.31-
7.28 (m, 5H), 7.26-7.24 (m, 1H), 7.22-7.16 (m, 1H), 7.13-7.10 
(m, 2H), 7.05-6.93 (m, 2H), 5.51-5.27 (m, 4H), 4.60 (d, J = 
9.1 Hz, 1H), 4.48 (d, J = 10.7 Hz, 2H), 4.42-4.35 (m, 2H), 
3.46 (dd, J = 9.1, 7.5 Hz, 1H), 3.26 (d, J = 7.5 Hz, 1H), 2.82-
2.79 (m, 2H), 2.11-1.91 (m, 4H), 1.79 (t, J = 11.7 Hz, 1H), 
1.48-1.04 (m, 19H), 0.94-0.89 (m, 3H). 13C NMR (75 MHz, 
CDCl3) δ: 175.3, 174.4, 171.5, 136.6, 135.7, 130.3, 130.0, 
129.2, 128.6, 128.5 , 128.2, 128.2, 128.0, 127.9, 127.1, 71.1, 
62.1, 61.8, 55.7, 50.3, 42.5, 35.1, 31.6, 29.6, 29.5, 29.4, 29.1, 
27.3, 27.2, 25.7, 23.7, 22.7, 14.2. LRMS (EI): m/z= 598 (M+, 
<1%), 527 (40), 525 (100), 377 (84), 144 (21), 91 (5 ). 






Yellow oil, (135 mg, 49% yield). Rf 0.46 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1253, 1364, 1690, 1736, 2855, 
2927, 3358, 3452 cm-1. 
1H NMR (300 MHz, CDCl3) δ: 7.48-
7.27 (m, 5H), 5.41-5.28 (m, 4H), 4.87 (d, J = 8.7 Hz, 1H), 
4.37 (q, J = 7.1 Hz, 2H), 3.55-3.46 (m, 1H), 3.10-3.01 (m, 
1H), 2.86 (dd, J = 13.8, 2.9 Hz, 1H), 2.77 (t, J = 6.2 Hz, 2H), 
2.32-2.21 (m, 2H), 2.08-1.87 (m, 7H), 1.76-1.64 (m, 1H), 
1.61-1.52 (m, 1H), 1.48-1.16 (m, 17H), 0.90-0.88 (m, 3H). 
13C NMR (75 MHz, CDCl3) δ 175.5, 175.0, 173.6, 130.3, 
130.2, 130.0, 128.2, 128.1, 128.0, 127.4, 66.2, 62.1, 45.6, 
39.9, 33.5, 33.0, 31.6, 29.8, 29.8, 29.7, 29.6, 29.5, 29.4, 29.3, 
27.3, 25.7, 25.3, 22.8, 22.7, 16.8, 14.4, 14.2. LRMS (EI): m/z 
= 550 (M+, <1%), 479 (80), 477 (100), 329 (36), 230 (17), 
156 (22), 91 (17), 55 (18). HRMS (EI): calcd. for C34H50N2O4 





Red oil, (149 mg, 54% yield). Rf 0.37 (hexane/ethyl acetate: 
7/3). IR (neat) ʋmax: 1265, 1387, 1732, 1778, 2854, 2925, 
3372 cm-1. 
1H NMR (300 MHz, CDCl3) δ: 7.31-7.28 (m, 5H), 
5.43-5.28 (m, 4H), 4.80 (s, 1H), 4.35 (q, J = 7.1 Hz, 2H), 
4.11- 4.05 (m, 1H), 3.69-3.62 (m, 2H), 3.25-3.12 (m, 1H), 
3.13 (s, 1H), 2.86 -2.76 (m, 2H), 2.23-2.15 (m, 1H), 2.13-1.96 
(m, 4H), 1.91 (dd, J = 12.4, 4.4 Hz, 1H), 1.83-1.70 (m, 1H), 
1.63-1.46 (m, 1H), 1.55-1.16 (m, 17H), 0.92-0.88 (m, 3H).13C 
NMR (75 MHz, CDCl3) δ: 172.6, 168.2, 152.7, 138.5, 130.2, 
130.0, 129.9, 128.5, 128.4, 128.0, 127.9, 127.3, 127.1, 71.2, 
66.0, 61.8, 47.2, 42.4, 39.5, 31.9, 31.5, 29.8, 29.7, 29.5, 29.3, 
29.1, 27.2, 25.62, 25.2, 22.7, 22.6, 14.3, 14.1. LRMS (EI): m/z 
= 552 (M+, <1%), 481 (97), 479 (100), 392 (26), 331 (58), 
198 (16), 170 (20), 156 (36), 91 (25), 55 (32). HRMS (EI): 






Yellow oil, (255 mg, 86% yield). Rf 0.43 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1127, 1165, 1325, 1706, 2856, 
2927, 3341, 3464 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.61 
(d, J = 8.7 Hz, 2H), 7.48 (d, J = 8.1 Hz, 2H), 5.53-5.20 (m, 
4H), 4.69 (d, J = 9.1 Hz, 1H), 4.36 (dd, J = 7.2, 4.6 Hz, 2H), 
3.56 (dd, J = 9.1, 7.5 Hz, 1H), 3.29 (d, J = 7.5 Hz, 1H), 2.81 
(s, 3H), 2.77 (t, J = 6.1 Hz, 1H), 2.06 (dd, J = 8.2, 5.2 Hz, 
4H), 1.95-1.65 (m, 1H), 1.52-1.14 (m, 19H), 0.96-0.86 (m, 
3H). 13C NMR (75 MHz, CDCl3) δ: 175.4, 174.4, 171.4, 
141.4, 132.5 (d, 1JC-F = 271.7 Hz, CF3), 130.5 (d, 
2JC-F = 32.7 
Hz, CHCF3), 130.3 129.8, 128.2, 127.8, 127.5, 125.4 (d, 
3JC-F 
= 3.7 Hz, CHCHCF3), 70.6, 61.7, 60.7, 55.0, 49.9, 34.9, 31.5, 
29.4, 29.3, 29.0, 27.2, 27.1, 25.6, 24.9, 23.6, 22.5, 14.1. 19F 
NMR δ: -62.5. LRMS (EI): m/z = 590 (M+, <1%), 519 (47), 
517 (100), 369 (83), 323 (22), 212 (26). HRMS (EI): calcd. 





Yellow oil, (190 mg, 72% yield). Rf 0.13 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1287, 1436, 1705, 1736, 2254, 
2855, 2927, 3007, 3314, 3464 cm-1. 
1H NMR (300 MHz, 
CDCl3) δ: 7.81 (d, J = 3.2 Hz, 1H), 7.35 (d, J = 3.2 Hz, 1H), 
5.44-5.29 (m, 4H), 5.05 (d, J = 9.0 Hz, 1H), 4.36 (dq, J = 7.1, 
3.8 Hz, 2H), 3.69 (t, J = 8.3 Hz, 1H), 3.32 (d, J = 7.5 Hz, 1H), 
2.84 (s, 3H), 2.77 (t, J = 6.0 Hz, 1H), 2.04 (q, J = 6.9, 5.0 Hz, 
4H), 1.86-1.57 (m, 1H), 1.48-1.16 (m, 19H), 0.90 (td, J = 6.9, 
5.9, 3.3 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.2, 174.4, 
170.8, 167.4, 142.8, 130.2, 129.9, 128.1, 127.8, 119.6, 71.1, 
61.7, 59.4, 55.7, 50.3, 35.6, 31.5, 29.5, 29.4, 29.3, 29.0, 27.2, 
27.1, 25.6, 25.0, 23.7, 22.6, 14.1. LRMS (EI): m/z= 529 (M+, 
<1%), 558 (48), 556 (100), 308 (47), 262 (15), 86 (2 ). 























Yellow oil, (160 mg, 60% yield). Rf 0.28 (hexane/ethyl 
acetate: 8/2). IR (neat) ʋmax: 1098, 1288, 1436, 1484, 1642, 
1703, 1736, 2959 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.38-
7.30 (m, 5H), 5.43-5.34 (m, 8H), 4.67 (d, J = 9.1 Hz, 1H), 
3.91 (s, 3H), 3.52 (dd, J = 9.2, 7.4 Hz, 1H), 3.27 (d, J = 7.4 
Hz, 1H), 2.82-2.77 (m, 9H), 2.19-2.16 (m, 1H), 2.11-1.99 (m, 
3H), 2.08-1.25 (m, 10H), 0.92-0.88 (m, 3H). 13C NMR (75 
MHz, CDCl3) δ: 175.8, 174.8, 172.1, 130.6, 129.3, 128.8, 
128.6, 128.6, 128.5, 128.2, 127.9, 127.8, 127.6, 127.0, 70.8, 
61.9, 55.8, 52.6, 50.6, 35.0, 31.6, 29.4, 27.3, 25.7, 25.6, 24.9, 
22.7, 22.0, 14.2. LRMS (EI): m/z = 532 (M+, <1%), 473 (35), 
341 (28), 327 (22), 287 (100), 254 (26), 241 (21), 193 (23), 
130 (29), 91 (21). HRMS (EI): calcd. for C33H44N2O4 






Yellow oil, (168 mg, 56% yield). Rf 0.45 (hexane/ethyl 
acetate: 8/2). IR (neat) ʋmax: 1128, 1436, 1620, 1701, 1779, 
2858, 2929, 3012, 3349, 3460 cm-1.  1H NMR (300 MHz, 
CDCl3) δ 7.61 (d, J = 8.0 Hz, 2H), 7.47 (d, J = 8.0 Hz, 2H), 
5.57-5.19 (m, 8H), 4.69 (d, J = 8.6 Hz, 1H), 3.88 (s, 3H), 3.54 
(t, J = 8.2 Hz, 1H), 3.28 (d, J = 7.0 Hz, 1H), 2.88-2.61 (m, 
9H), 2.18-1.84 (m, 5H), 1.51-1.11 (m, 8H), 0.99-0.70 (m, 
3H). 13C NMR (75 MHz, CDCl3) δ: 175.4, 174.4, 171.8, 
141.2, 130.4 (d, 2JC-F = 32.9 Hz, CHCF3), 129.4, 128.7, 128.5, 
127.9, 127.7, 127.6, 127.45, 127.4, 125.4 (d, 3JC-F = 4.1 Hz, 
CHCHCF3), 70.7, 60.9, 55.3, 52.6, 50.0, 34.7, 31.5, 29.3, 
27.2, 25.6, 25.5, 24.9, 22.5, 21.9, 14.1. 19F NMR δ: -63.0. 
LRMS (EI): m/z = 600 (M+, <1%), 541 (27), 395 (23), 355 
(100), 322 (25), 210 (25), 91 (18), 67 (23). HRMS (EI): calcd. 





Yellow oil, (210 mg, 74% yield). Rf 0.40 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1130, 1288, 1382, 1438, 1702, 
2965, 3060, 3454 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.36-
7.34 (m, 5H), 5.62-5.31 (m, 12H), 4.68 (d, J = 9.1 Hz, 1H), 
4.35 (qd, J = 7.1, 0.9 Hz, 2H), 3.54 (dd, J = 9.2, 7.5 Hz, 1H), 
3.33 (d, J = 7.4 Hz, 1H), 3.06-2.76 (m, 13H), 2.66 (dd, J = 
14.5, 7.8 Hz, 1H), 2.09 (tt, J = 8.2, 1.2 Hz, 3H), 1.40 (t, J = 
7.2 Hz, 3H), 0.99 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, 
CDCl3) δ: 175.6, 174.7, 171.3, 137.3, 132.8, 132.1, 130.2, 
129.8, 129.1, 128.8, 128.6, 128.4, 128.4, 127.9, 127.8, 127.8, 
127.5, 127.1, 127.0, 122.5, 70.2, 61.8, 61.6, 54.5, 50.1, 33.1, 
26.0, 25.7, 25.6, 25.5, 24.8, 20.6, 14.3, 14.1, 13.9. LRMS 
(EI): m/z = 570 (M+, <1%), 370 (17), 369 (89), 301 (100), 211 







Yellow oil, (220 mg, 66% yield). Rf 0.54 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1224, 1396, 1510, 1707, 2932, 
2964, 3012, 3345, 3467 cm-1. 1H NMR (300 MHz, CDCl3) δ: 
7.34-7.07 (m, 7H), 6.99 (t, J = 8.7 Hz, 2H), 5.52-5.22 (m, 
12H), 4.63 (d, J = 9.2 Hz, 1H), 4.44 (d, J = 7.1 Hz, 2H), 4.39-
4.32 (m, 2H), 3.47 (dt, J = 8.7, 6.2 Hz, 1H), 3.31 (d, J = 7.6 
Hz, 1H), 3.10-2.63 (m, 10H), 2.64 (dd, J = 14.5, 7.8 Hz, 1H), 
2.17-1.97 (m, 3H) 2.20-1.92 (m, 3H), 1.39 (t, J = 7.2 Hz, 3H), 
0.99 (t, J = 7.5 Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.1, 
174.2, 171.1, 162.44 (d, 1JC-F = 246.5 Hz, CF), 136.8, 132.8, 
132.1, 131.5 (d, 4JC-F = 3.3 Hz, CCHCHCF), 131.0 (d, 
3JC-F = 
8.2 Hz, CHCHCF) , 129.7, 129.0, 128.8, 128.6, 128.4, 128.4, 
128.3, 128.2, 127.9, 127.8, 127.8, 127.5, 127.1, 127.0, 122.5, 
115.3 (d, 2JC-F = 21.4 Hz, CHCF), 70.4, 61.8, 61.7, 54.6, 49.8, 
41.7, 33.0, 26.0, 25.7, 25.6, 25.5, 20.5, 14.3, 14.1. 19F NMR δ: 
-114.2.  LRMS (EI): m/z = 664 (M+, <1%), 396 (24), 395 
(100), 144 (15), 109 (41), 91 (15), 79 (13). HRMS (EI): calcd. 






Yellow oil, (200 mg, 69% yield). Rf 0.17 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1098, 1288, 1381, 1435, 1705, 
2934, 2967, 3401 cm-1. 1H NMR (300 MHz, CDCl3) δ 7.76 (d, 
J = 3.2 Hz, 1H), 7.31 (d, J = 3.2 Hz, 1H), 5.59-5.19 (m, 12H), 
5.02 (d, J = 9.1 Hz, 1H), 4.31 (qd, J = 7.2, 1.2 Hz, 2H), 3.76-
3.57 (m, 1H), 3.35 (d, J = 7.5 Hz, 1H), 3.30 (dd, J = 7.6, 3.0 
Hz, 1H), 3.02-2.59 (m, 13H), 2.52 (dd, J = 14.4, 7.5 Hz, 1H), 
1.36 (t, J = 7.2 Hz, 3H), 0.96 (t, J = 7.5 Hz, 3H). 13C NMR 
(75 MHz, CDCl3) δ: 175.1, 174.3, 170.5, 167.8, 143.0, 133.0, 
132.1, 128.9, 128.7, 128.5, 128.4, 128.1, 128.0, 127.9, 127.5, 
127.1, 122.5, 119.7, 70.9, 62.0, 59.6, 54.9, 50.2, 33.7, 26.1, 
25.8, 25.7, 25.6, 25.2, 20.7, 14.4, 14.2. LRMS (EI): m/z = 577 
(M+, <1%), 308 (100), 262 (6), 177 (7), 91 (5). HRMS (EI): 






Yellow oil, (200 mg, 63% yield). Rf 0.43 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1127, 1325, 1707, 2930, 2962, 
3013, 3342, 3471 cm-1. 1H NMR (300 MHz, CDCl3) δ: 7.59 
(dd, J = 5.7, 3.3 Hz, 2H), 7.46 (dd, J = 5.7, 3.3 Hz, 2H), 5.47-
5.12 (m, 12H), 4.72 (d, J = 9.2 Hz, 1H), 4.33 (qd, J = 7.2, 0.9 
Hz, 2H), 3.57 (dd, J = 9.2, 7.4 Hz, 1H), 3.33 (d, J = 7.2 Hz, 
1H), 2.91-2.79 (m, 13H), 2.65 (dd, J = 14.5, 7.8 Hz, 1H), 
2.12-2.01 (m, 3H), 1.38 (t, J = 7.2 Hz, 3H), 0.96 (t, J = 7.5 
Hz, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.3, 174.3, 171.0, 
141.5, 134.1, 132.1, 132.0 (d, 1JC-F = 271.7 Hz, CF3), 130.5, 
(d, 2JC-F = 32.3 Hz, CHCF3), 128.9, 128.6, 128.6, 128.5, 128.4, 
127.9, 127.8, 127.7, 127.6, 127.5, 127.3, 126.9, 125.4, 125.3 
(d, 3JC-F = 3.9 Hz, CHCHCF3) 122.2 (d, 
4JC-F = 1.3 Hz, 
CCHCHCF3), 70.1, 61.9, 60.8, 54.1, 49.7, 49.4, 33.0, 27.0, 














δ: -62.5. LRMS (EI): m/z = 638 (M+, <1%), 370 (20), 369 
(100), 301 (43), 212 (16), 91 (7). HRMS (EI): calcd. for 





Yellow oil, (205 mg, 75% yield). Rf 0.45 (hexane/ethyl 
acetate: 7/3). IR (neat) ʋmax: 1287, 1383, 1435, 1705, 1779, 
2854, 2925, 3343, 3466 cm-1. 1H NMR (300 MHz, CDCl3) δ: 
7.40-7.30 (m, 5H), 5.42-5.30 (m, 2H), 4.67 (d, J = 9.2 Hz, 
1H), 4.43-4.24 (m, 2H), 3.53 (dd, J = 9.2, 7.4 Hz, 1H), 3.27 
(d, J = 7.5 Hz, 1H), 2.82 (s, 3H), 2.12-1.94 (m, 4H), 1.84-1.76 
(m, 1H), 1.531.17 (m, 27H), 0.99-0.87 (m, 3H). 13C NMR (75 
MHz, CDCl3) δ: 175.7, 174.9, 171.7, 137.2, 130.2, 129.7, 
128.6, 128.5, 127.1, 70.8, 61.8, 55.5, 50.5, 35.1, 32.0, 29.8, 
29.8, 29.6, 29.5, 29.4, 29.1, 27.3, 27.2, 24.9, 23.7, 22.8, 14.2, 
14.2. LRMS (EI): m/z = 538 (M+, <1%), 465 (100), 439 (19), 
301 (83), 254 (34), 241 (22), 156 (27), 55(17). HRMS (EI): 
calcd. for C33H50N2O4  538.3771; found 538.3763. 
 
4.6. General procedure for preparation of α-amino ester 11a. 
 
Synthesis of N-tert-butylsulfinyl imine 8: powdered IBX 
(4.20 g, 15 mmol) was added to a solution of alcohol 7a (2.68 
g, 5 mmol) with acetonitrile. It was stirred 4 h at 80 °C. 
Filtration of the reaction mixture over a short-pad of silica 
give the corresponding pure aldehyde.15 Then, a solution of 
tert-butanesulfinamide (0.67 g, 5.5 mmol) was added to the 
corresponding aldehyde (1.33 g, 5 mmol) in dry THF (20 mL) 
under argon atmosphere at 23 °C. Titanium tetraethoxide 
(2.23 g, 2.09 mL, 10 mmol) was slowly added and it was 
stirred for 12 h at the room temperature. The resulting mixture 
was hydrolyzed with brine, extracted with ethyl acet t , dried 
over anhydrous MgSO4, and evaporated. The residue was 
purified by column chromatography (Hexane/AcOEt) to yield 




Yellow oil, (1.42 g, 77% yield). Rf 0.28 (hexane/ethyl acetate: 
9/1). IR (neat) ʋmax: 1088, 1363, 1458, 1622, 2854, 2924 cm
-1. 
1H NMR (300 MHz, CDCl3) δ 8.07 (t, J = 4.8 Hz, 1H), 5.40-
5.32 (m, 2H), 2.52 (td, J = 7.4, 4.7 Hz, 2H), 2.02 (q, J = 5.9 
Hz, 4H), 1.66-1.59 (m, 2H), 1.42-1.20 (m, 29H), 1.20 (s, 9H), 
0.95-0.78 (m, 3H).13C NMR (75 MHz, CDCl3) δ: 169.8, 
130.0, 129.7, 56.5, 36.1, 31.9, 29.8, 29.7, 29.6, 29.5, 29.3, 
29.2, 29.2, 29.1, 27.2, 27.1, 25.5, 22.7, 22.3, 14.1. LRMS 
(EI): m/z = 369 (M+, <1%), 313 (34), 264 (12), 57 (100), 41 
(17). HRMS (EI): calcd. for C22H43NOS (M
+ - C4H9SO) 
264.2691; found 264.2697. 
 
Synthesis of β-nitroamine derivative 9a: a heterogeneous 
mixture of nitromethane (0.56 g, 0.50 mL, 9.0 mmol) and the 
corresponding N-tert-butylsulfinyl imine 8a (1.11 g, 3.0 
mmol) was added NaOMe/MeOH (10 mol%) dropwise and 
the mixture was stirred at room temperature 12 h. Te 
resulting mixture was hydrolyzed with water, acidified with 
1M hydrochloric acid, extracted with ethyl acetate, dried over 
anhydrous MgSO4, and evaporated. The residue was purified 
by column chromatography (silica gel, Hexane/AcOEt) to 




Yellow oil, (0.90 g, 70% yield). Rf 0.50 (hexane/ethyl acetate: 
1/1). IR (neat) ʋmax: 1048, 1378, 1465, 1553, 1740, 2854, 
2925, 3199, 3402 cm-1. 1H NMR (300 MHz, CDCl3) δ 5.37-
5.28 (m, 2H), 4.70-4.63 (m, 2H), 4.12 (d, J = 9.3 Hz, 1H), 
3.76 (dq, J = 8.9, 4.8 Hz, 1H), 1.99 (q, J = 6.5 Hz, 4H), 1.60-
1.50 (m, 2H), 1.48-1.41 (m, 1H), 1.39-1.16 (m, 31H), 0.92-
0.74 (m, 3H).13C NMR (75 MHz, CDCl3) δ: 130.0, 129.6, 
79.8, 55.2, 33.1, 31.9, 29.7, 29.7, 29.6, 29.5, 29.3, 29.1, 29.0, 
27.2, 27.1, 25.8, 22.7, 22.6, 14.1. LRMS (EI): m/z= 430 (M+, 
<1%), 313 (16), 374 (7), 264 (10), 69 (10), 57 (100), 41 (16). 
HRMS (EI): calcd. for C23H46N2O3S 430.3229; found 
430.3233. 
Synthesis of α-amino acid derivative 10a: solid NaNO2 (414 
mg, 6.0 mmol) was added to a stirred solution of comp und 
9a (0.39 g, 1 mmol) and AcOH (0.30 mg, 0.29 mL, 5 mmol) 
in a 7:1 mixture of DMF and water (2.5 mL) at 23 °C. The 
reaction was heated at 45 °C for 12 h, after which it was 
quenched with a 2 M NaOH water solution until pH = 6 and 
extracted with MTBE, dried over anhydrous MgSO4 and 
evaporated to give pure compound. 
(Z)-2-[(tert-butylsulfinyl)amino]nonadec-10-enoic acid 10a. 
Yellow oil, (170 mg, 41% yield). Rf 0.47 
(dichloromethane/methanol: 9/1). IR (neat) ʋmax: 1029, 1254, 
1463, 1651, 1725, 2854, 2925, 3270, 3417. 1H NMR (300 
MHz, CDCl3) δ 5.37-5.30 (m, 2H), 4.54 (s, 1H), 3.84 (d, J = 
9.3 Hz, 1H), 1.99 (q, J = 6.5 Hz, 4H), 1.77 (d, J = 5.5 Hz, 
1H), 1.65 (dd, J = 13.1, 5.7 Hz, 1H), 1.44-1.05 (m, 31H), 
0.90-0.85 (m, 3H). 13C NMR (75 MHz, CDCl3) δ: 175.2, 
130.4, 130.2, 59.0, 56.6, 34.0, 32.6, 31.9, 29.7, 29.6, 29.5, 
29.3, 29.2, 29.0, 25.3, 22.8, 22.6, 14.1. LRMS (EI): m/z = 415 
(M+, <1%), 359 (19), 310 (18), 287 (19), 266 (33), 57 (100). 
HRMS (EI): calcd. for C23H45NO3S 415.3120; found 
415.3109. 
 
Synthesis of α-amino ester 11a: a solution of 10a (0.083 g, 0.2 
mmol) in EtOH was added H2SO4. The mixture was stirred 
overnight at 40 °C. It was quenched with NaHCO3 until pH=7 
and solvent was evaporated. It was extracted with AcOEt, 
dried over anhydrous MgSO4 and evaporated to give pure 
compound. 
 
Ethyl (Z)-2-aminononadec-10-enoate 11a. 
Yellow oil, (56 mg, 82% yield). Rf 0.50 
(dichloromethane/methanol: 9/1). IR (neat) ʋmax: 1180, 1465, 
1736, 2853, 2922, 3196, 3311, 3371 cm-1 .1H NMR (300 
MHz, CDCl3) δ: 5.38 (dt, J = 4.9, 2.5 Hz, 2H), 4.37-3.82 (m, 
2H), 2.06-1.87 (m, 4H), 1.83-1.70 (m, 1H), 1.63 (d, J = 6.3 
Hz, 1H), 1.27 (d, J = 45.9 Hz, 3H), 0.94-0.80 (m, 3H).13C 
NMR (75 MHz, CDCl3) δ: 175.4, 130.4, 130.1,65.7, 62.1, 
32.6, 31.9, 29.6, 29.4, 29.3, 29.1, 29.1, 27.2, 22.6, 1.5, 15.8, 
14.1. LRMS (EI): m/z = 339 (M+, <1%), 268 (16), 267(27), 
266 (100), 240 (14), 57(19), 55(20). HRMS (EI): calcd. for 
C21H41NO 339.3137; found 339.3132. 
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